Cargando…
The association between blood MxA mRNA and long-term disease activity in early multiple sclerosis
BACKGROUND: Myxovirus resistance protein A (MxA) is a protein that is upregulated by interferon-beta. Homeostatic MxA mRNA levels are potentially correlated with inflammatory disease activity in multiple sclerosis (MS) and could have an important role in MS pathology. AIM: To investigate the associa...
Autores principales: | Coerver, Eline M. E., Strijbis, Eva M. M., Petzold, Laura F., Van Kempen, Zoé L. E., Jasperse, Bas, Barkhof, Frederik, Oudejans, Cees B. M., Uitdehaag, Bernard M. J., Teunissen, Charlotte E., Killestein, Joep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428291/ https://www.ncbi.nlm.nih.gov/pubmed/36062003 http://dx.doi.org/10.3389/fneur.2022.907245 |
Ejemplares similares
-
Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light
por: Wessels, Mark HJ, et al.
Publicado: (2023) -
Baseline MxA mRNA Expression Predicts Interferon Beta Response in Multiple Sclerosis Patients
por: Matas, Elisabet, et al.
Publicado: (2014) -
Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients
por: van Lierop, ZYGJ, et al.
Publicado: (2021) -
Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab
por: Toorop, Alyssa A., et al.
Publicado: (2020) -
MxA mRNA Quantification and Disability Progression in Interferon Beta-Treated Multiple Sclerosis Patients
por: Serana, Federico, et al.
Publicado: (2014)